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therapy alone3. Despite numerous available antidepres-
sants with different action mechanisms, it is sometimes 
very demanding to fi nd a medication that will be effective 
enough in an individual patient, and in cases where mono-
therapy does not lead to satisfactory symptom remission 
or in treatment resistant cases, combinations of psycho-
tropic medications can be applied. Polypharmacy (lat. 
polypragmasia) in psychiatry refers to the concurrent use 
of two or more psychotropic medications in a patient4, and 
is a common practice in the treatment of psychiatric pa-
tients5–8. Although in many cases necessary, polyphar-
macy in psychiatry is accompanied by a much greater risk 
for drug interactions and adverse effects, sometimes even 
life-threatening9. 
Case Report 
A 67-year-old patient had a depressive episode ten 
years ago, for which she was in psychiatric treatment. 
Medication was taken regularly the whole time. In the 
meanwhile she was diagnosed with hypertension, glau-
Introduction 
Depression is a common, often long-lasting and recur-
rent mental disorder that signifi cantly impairs a person’s 
functioning, leads to a serious sufferring and diminished 
quality of life of the person affected with depression. The 
incidence of depression increases in the last decades so 
depression is becoming a major public health issue, and 
World Health Organization states that depression is the 
leading cause of disability as measured by Years Lived 
with Disability1.
Besides depressed mood, depression includes other 
emotional, motivational, behavioral, somatic and cognitive 
symptoms, and clinical presentation of depression varies 
among patients. Many physical illnesses can mimic de-
pression, and many medications have unwanted pro-de-
pressive effects, that is often overlooked. 
It has been repeatedly proven that best results in treat-
ment of depression can be achieved by combined therapy, 
combination of antidepressant medications and various 
modalities of psychotherapy2, as compared to medication 
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A B S T R A C T 
Depression is an illness of modern society, which affects population of different age. Etiological factors differ, and 
frustration factors as a cause of depression are multiplying.  Each new episode presents diffi culties, both for patients and 
psychiatrists. Despite the increasing number of antidepressants we use in treatment, it is sometimes hard to notice an 
effi cient antidepressant in an optimal-effi cient dose. In resistant cases we apply combinations of psychopharmacs, and 
the choice of the same depends on the leading symptoms. We will present the case of a 67-year old patient where a depres-
sive episode (in the terms of a reccurent major depressive disorder) lasts for one year. During this period she was treated 
as outpatient and inpatient with several antidepresants in combinations with other psychopharmacotherapeutical drugs. 
Despite regular treatment, mental state was worsening. Clinical presentation was indicating developing of dementia 
(behavior, cognition outges), which we excluded through diagnostic process. Psychopharmacological combinations  (an-
tidepresants, mood stabilizators, antypschotics, anxsiolotix)  were not effi cant. Progression of simptoms leads to rehospi-
talisation. In further treatmen, we followed the principle «Less is more» which resulted with an expected and satisfactory 
outcome.
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coma and osteoporosis, for which she took medications. A 
second depressive episode appeared gradually about one 
year ago, and was partially caused by family problems. 
The documentation shows that she was anxious, tense and 
irritable, with sleep disturbance, loss of appetite and a 
drop in body weight. She was diagnosed with recurrent 
major depressive disorder (current episode severe, without 
psychotic symptoms F 33.2.). For several months was con-
ducted a titration psychopharmacological drugs (car-
bamazepine 200 mg/day, fl uvoxamine 100 mg/day, ox-
azepam 60 mg/day fl urazepam 15 mg), and given the lack 
of effect of this treatment, maprotilin 75 mg/day and olan-
zapine 5 mg/day (then 10 mg/day), and later duloxetin 
(doses up to 120 mg/day), were introduced.
Despite regular treatment there is no improvement in 
mental condition, there is a progression of depressive 
symptoms in terms of increased restlessness, forgetful-
ness, and suicidality, which led to hospitalization, during 
which she underwent diagnostic procedures (laboratory 
located in benchmarking, ophthalmologist-glaucoma, 
brain CT – normal morphological fi ndings). Correction in 
therapy was carried out: duloxetin 90 mg/day, olanzapine 
5 mg/day, carbamazepine CR 400 mg/day, oxazepam 45 
mg/day. After 14 days, she was discharged from hospital 
treatment, with a partly improved mental condition.
Over the next month, the situation was getting worse 
again, despite the regular use of drugs. The patient com-
plains of sedation, states somatisations (bad sight despite 
the glasses, a long-term constipation), and according to her 
family, delusions occur with depressive ideas from the 
health sphere. She was re-hospitalized.
Clinical observation was performed in a hospital set-
ting, and reveals a progressive psychopathology pro-
nounced in afternoon and evening hours, when she shows 
health sphere delusions with severe psychomotor agitation 
and stubborn insomnia, and cognitive defi cits similar to 
dementia (which was excluded during the previous hospi-
talization). Therapy was discontinued, and the minimum 
dose of clozapine (25 mg in the evening), along with mir-
tazapin 30 mg and 400 mg carbamazepine CR, shows im-
provement. In ambulatory conditions leads to improve-
ment of the situation, the leading symptomatology is 
docked, according to information by the family she is func-
tional in everyday life situations.
Discussion 
Depression is the most common mental disorder and a 
common cause of disability in the elderly10. Depression in 
older people has specifi c features, such as psychomotor 
symptoms, somatizations, metabolic and electrolyte im-
balance due to reduced food and liquid intake, and rather 
often a domination of cognitive symptoms that resemble 
dementia, a symptom known as pseudodementia, depres-
sive pseudodementia. Depressive pseudodementia is dis-
tinguished from primary dementia by its acute onset with-
out prior cognitive disturbance, history of past mood 
disorder episodes, psychomotor retardation, diurnal cogni-
tive dysfunction and subjective memory dysfunction in 
excess of objective fi ndings11. 
There are therapeutic guidelines (algorithms) for treat-
ment of different psychiatric illnesses as well as depres-
sion. Antidepressants are used in the treatment of depres-
sion, however, at times, a depressive disorder can 
assimilate a psychotic feature with pronounced delusions, 
it is indicated that the addition of lower to medium doses 
of antipsychotics can be effective. The selection of antide-
pressanst and antipsychotics in the treatment of psychot-
ic depression is completely up to the psychiatrists’ choice. 
Depending on the clinical picture of a disease, we tend 
to use combinations of medications that vary in pharma-
cological profi le and effect in order to alter the symptoms 
of depression. However, psycho pharmacotherapy is not 
always adequate for healing12.  
When treating depressed elderly patients it is inevi-
table to consider all the characteristics of their age and 
the fact that depression in most patients occurs in comor-
bidity with physical illnesses that are usually under 
therapy of more medications, and consequently polyphar-
macy is often a rule in patients of older age. In older age, 
due to physiological changes and physical co morbidities, 
medications have altered pharmacokinetic and pharma-
codynamic properties, medication metabolism, absorp-
tion, distribution and elimination is changed13. Since 
older patients are more sensitive to medications, more 
prone to adverse effects and medication interactions, and 
medications are metabolized slower, lower doses of (psy-
chotropic) medications, with a more gradual titration, are 
needed. 
Many medications, for physical illnesses or psychotro-
pic ones, alone and more when combined in elderly pa-
tients, can lead to changes in mental status, cause confu-
sion, decline in cognitive abilities14, and depressive 
symptoms, that can mislead to diagnose dementia process 
or depression. The negative impact of depression on pa-
tient life quality is well known since it causes various psy-
chosocial problems15. We also need to have in mind, serous 
cognitive defi cits cause impairment in occupational and 
social functioning16.
Conslussion
In treatment of depression an individual approach 
must prevail, with consideration of all patient’s character-
istics. Psychotropic medications can cause adverse effects 
of all organ systems, especially in psychotropic polyphar-
macy and in older patients, so monotherapy in a suffi cient 
medication dose and appropriate duration should, when 
possible, be preferred in treatment of depression. Given 
that the elderly are more sensitive to the use of psychop-
harmacological drugs, even lower dose of psychopharma-
cological drugs can have a therapeutic effect. Since each 
patient is specifi c, therapeutic doses of psychopharmaco-
logical must be individually tailored to each patient.
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MANJE JE VIŠE – MOGUĆA OPCIJA U LIJEČENJU DEPRESIJE
S A Ž E T A K
Depresija je bolest suvremenog društva, koja zahvaća populaciju različite životne dobi. Etiološki čimbenici su različiti, 
a frustracijskih čimbenika kao uzroka nastanka depresije sve je više. Svaka nova epizoda predstavlja poteškoću kako 
za bolesnika tako i za psihijatra. Unatoč sve većem broju antidepresiva koje koristimo u liječenju ponekada je teško 
primijeniti djelotvoran antidepresiv u optimalnoj-djelotvornoj dozi. U rezistentnim slučajevima primjenjujemo kombi-
nacije psihofarmaka, a izbor istih ovisi o vodećim simptomima. Prikazati ćemo slučaj 67-godišnje bolesnice u koje depre-
sivna epizoda (u okvirima povratnog depresivnog poremećaja) traje zadnjih godinu dana. Tijekom navedenog perioda 
liječena je ambulantno i hospitalno sa nekoliko antidepresiva u kombinaciji sa drugim psihofarmacima. Unatoč redovitom 
liječenju psihičko stanje se pogoršavalo tijekom ambulantnog i hospitalnog liječenja Klinička slika nalikovala je dement-
nom razvoju (ponašanje, kognitivni ispadi), što smo dijagnostički isključili. Kombinacije više psihofarmaka (antidepre-
siva, stabilizatora raspoloženja, antipsihotika, anksiolitika) nisu dale nikakve rezultate. Progresija simptoma rezulti-
rala je ponovnom hospitalizacijom. U liječenju smo se vodili principom „manje je više“ što je konačno dalo očekivane 
rezultate.
